Collage of published research papers

Citation

BibTex format

@article{Graham:2020:10.1016/j.jinf.2020.05.073,
author = {Graham, N and Junghans, C and Downes, R and Sendall, C and Lai, H and McKirdy, A and Elliott, P and Howard, R and Wingfield, D and Priestman, M and Ciechonska, M and Cameron, L and Storch, M and Crone, MA and Freemont, PS and Randell, P and McLaren, R and Lang, N and Ladhani, S and Sanderson, F and Sharp, DJ},
doi = {10.1016/j.jinf.2020.05.073},
journal = {Journal of Infection},
pages = {411--419},
title = {SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes},
url = {http://dx.doi.org/10.1016/j.jinf.2020.05.073},
volume = {81},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - OBJECTIVES: To understand SARS-Co-V-2 infection and transmission in UK nursing homes in order to develop preventive strategies for protecting the frail elderly residents. METHODS: An outbreak investigation involving 394 residents and 70 staff, was carried out in 4 nursing homes affected by COVID-19 outbreaks in central London. Two point-prevalence surveys were performed one week apart where residents underwent SARS-CoV-2 testing and had relevant symptoms documented. Asymptomatic staff from three of the four homes were also offered SARS-CoV-2 testing. RESULTS: Overall, 26% (95% CI 22 to 31) of residents died over the two-month period. All-cause mortality increased by 203% (95% CI 70 to 336) compared with previous years. Systematic testing identified 40% (95% CI 35 to 46) of residents as positive for SARS-CoV-2, and of these 43% (95% CI 34 to 52) were asymptomatic and 18% (95% CI 11 to 24) had only atypical symptoms; 4% (95% CI -1 to 9) of asymptomatic staff also tested positive. CONCLUSIONS: The SARS-CoV-2 outbreak in four UK nursing homes was associated with very high infection and mortality rates. Many residents developed either atypical or no discernible symptoms. A number of asymptomatic staff members also tested positive, suggesting a role for regular screening of both residents and staff in mitigating future outbreaks.
AU - Graham,N
AU - Junghans,C
AU - Downes,R
AU - Sendall,C
AU - Lai,H
AU - McKirdy,A
AU - Elliott,P
AU - Howard,R
AU - Wingfield,D
AU - Priestman,M
AU - Ciechonska,M
AU - Cameron,L
AU - Storch,M
AU - Crone,MA
AU - Freemont,PS
AU - Randell,P
AU - McLaren,R
AU - Lang,N
AU - Ladhani,S
AU - Sanderson,F
AU - Sharp,DJ
DO - 10.1016/j.jinf.2020.05.073
EP - 419
PY - 2020///
SN - 0163-4453
SP - 411
TI - SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes
T2 - Journal of Infection
UR - http://dx.doi.org/10.1016/j.jinf.2020.05.073
UR - https://www.ncbi.nlm.nih.gov/pubmed/32504743
UR - https://www.sciencedirect.com/science/article/pii/S0163445320303480?via%3Dihub
UR - http://hdl.handle.net/10044/1/79885
VL - 81
ER -

Awards

  • Finalist: Best Paper - IEEE Transactions on Mechatronics (awarded June 2021)

  • Finalist: IEEE Transactions on Mechatronics; 1 of 5 finalists for Best Paper in Journal

  • Winner: UK Institute of Mechanical Engineers (IMECHE) Healthcare Technologies Early Career Award (awarded June 2021): Awarded to Maria Lima (UKDRI CR&T PhD candidate)

  • Winner: Sony Start-up Acceleration Program (awarded May 2021): Spinout company Serg Tech awarded (1 of 4 companies in all of Europe) a place in Sony corporation start-up boot camp

  • “An Extended Complementary Filter for Full-Body MARG Orientation Estimation” (CR&T authors: S Wilson, R Vaidyanathan)

UK DRI


Established in 2017 by its principal funder the Medical Research Council, in partnership with Alzheimer's Society and Alzheimer’s Research UK, The UK Dementia Research Institute (UK DRI) is the UK’s leading biomedical research institute dedicated to neurodegenerative diseases.